Results 111 to 120 of about 4,824,475 (194)
Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer
Molecular Oncology, EarlyView.This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane +9 morewiley +1 more sourceThe Journal of Comparative Neurology, Table of Content, Vol. 524, No. 18, December 15, 2016 [PDF]
, 2016 Jason Pipkin, Eric Bushong, Mark Ellisman, William Kristan, Lena Iwai-Takekoshi, Anna Ramos, Ari Schaler, Samuel Weinreb, Richard Blazeski, Carol Mason, Rajae Talbi, Paul Klosen, Marie-Pierre Laran-Chich, Seloua Ouezzani, Vale rie Simonneaux, Rachel Anderson, Ryan Glanz, Shane Johnson, Mary Miller, Sara Romig-Martin, Jason Radley, Cristian Gutierrez-Ibanez, Andrew Iwaniuk, Megan Jensen, David Graham, Akos Poga, Benjamin Mongomery, James Stafford, Harald Luksch, Douglas Wylie, Grethe Olsen, Menno Witter, Meng-Lin Liao, Wei-Hau Peng, Daphne Kan, Chung-Liang Chien, Michael Condro, Anna Matynia, Nicholas Foster, Yukio Ago, Abha Rajbhandari, Christina Van, Bhavaani Jayaram, Sachin Parikh, Anna Diep, Eileen Nguyen, Victor May, Hong-Wei Dong, James Waschek, Ryota Matsuo, Marin Tanaka, Rena Fukata, Suguru Kobayashi, Hitoshi Aonuma, Yuko Matsuo, Christopher Von Bartheld, Jami Bahney, Suzana Herculano-Houzel +57 moreopenalex +1 more sourceBridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme +8 morewiley +1 more sourceIssue Information ‐ Table of Content [PDF]
, 2016 Gustavo Ram rez, Francisco Rodr guez, O scar Quesada, Pedro Herra ez, Antonio Ferna ndez, Antonio Espinosa-De-Los-Monteros, S Paul, M Lester, K Foreman, L Dibble, Feng Zhao, Jing Li, Linlong Mo, Min Tan, Ting Zhang, Yong Tang, Yuanyu Zhao, Sami Safi, Jens Ellrich, Winfried Neuhuber, Maddalena Botti, Luisa Ragionieri, Antonio Cacchioli, Rino Panu, Ferdinando Gazza, Tsutomu Miyake, Minayori Kumamoto, Masamitsu Iwata, Ryuichi Sato, Masataka Okabe, Hiroshi Koie, Nori Kumai, Kenichi Fujii, Koji Matsuzaki, Chiho Nakamura, Shinya Yamauchi, Kosuke Yoshida, Kohtaroh Yoshimura, Akira Komoda, Teruya Uyeno, Yoshitaka Abe, Rui Diogo, Gaelle Bello-Hellegouarch, Tiana Kohlsdorf, Borja Esteve-Altava, Julia Molnar, Naglaa Bayomy, Gehan Soliman, Eman Abdelaziz, Dawei Han, Bruce Young, Daniel Rider, Hisako Furusho, Shuang Xu, Alexander Trachtenberg, Winston Kuo, Kimito Hirai, Mako Susa, Laila Bahammam, Philip Stashenko, Akira Fujimura, Hajime Sasaki, Yuko Matoba, Naoko Nonaka, Yoshitoki Takagi, Eisaku Imamura, Masayuki Narukawa, Tomoya Nakamachi, Seiji Shioda, William Banks, Masanori Nakamura, Zhen Yang, Qian Li, Sanqiao Yao, Ge Zhang, Rong Xue, Guoliang Li, Yizheng Wang, Shixin Wang, Ruichang Wu, Hongsheng Gao, Sibel Atesoglu, Deniz Senol, Selahattin Balsak, Fuat Alakus, Davut Ozbag, Umut Dag +85 moreopenalex +3 more sourcesAdenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer
Molecular Oncology, EarlyView.A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski +14 morewiley +1 more source
